News and Events

Jan 29, 2019

The National Cancer Institute (NCI), through the NCI Technology Transfer Center (TTC), now offers a term-limited, exclusive Start-Up Evaluation Option License to start-up companies developing early-stage vaccine, therapeutic, device, and certain diagnostic technologies. The previous Start-up Program offered by the NIH Office of Technology Transfer will apply if companies submitted a license application for a start-up agreement on or before October 15, 2017.

Jan 3, 2019

Proposal(s) are sought in response to RFP # NIH-OD-OLAO-OA-(PLS)-2019 for Patent-Legal Services. This solicitation is full and open to ALL capable business concerns in the U.S. The North American Industry Classification System (NAICS) code for this acquisition is 541110 - Office of Lawyers.

Nov 20, 2018

The NIH’s tech transfer community is pursuing new law firm contracts for managing patent prosecution matters as the current contracts end Spring of 2019. As part of the development for the new Request For Proposals (RFP), the community is providing the public with the chance to comment or ask questions prior to the final RFP posting. A new pre-solicitation notice was recently posted on; the deadline to submit questions and comments is November 30, 2018 10 am Eastern Time.

Sep 18, 2018

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation.  Among them is Michael Redmond, chief of NEI’s Laboratory of Retinal Cell and Molecular Biology.

Sep 18, 2018
Jul 19, 2018
Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a sustained-release formulation (called SR-exenatide) that shows promise against Parkinson's disease. 
Apr 19, 2018

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health recently report that genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus. Single infusions of each modified bNAb protected two groups of six monkeys each against weekly exposures to simian-human immunodeficiency virus (SHIV) for up to 37 weeks.

Apr 18, 2018
Dr. Jorge Munoz will discuss the CDC Trioplex real-time RT-PCR assay for detection and differentiation of Zika, dengue and chikungunya virus infections in one clinical sample. To participate, please pre-register by sending an email to by Thursday, April 26, at 1 p.m. EDT. After requesting the registration, participants will receive a confirmation of their registration along with access information to enter prior to the webinar.
Mar 21, 2018

NIH building 1Health and Human Services (HHS) tops Reuters’ second annual ranking of the Top 25 Global Innovators – Government, a list that identifies and ranks the publicly funded ins

Mar 15, 2018

klebsiella bacteria